Ventricles of the Brain - Anatomy

Overview Diagrams (Figure 5.11)

1. Lateral Ventricles (Formerly 1st and 2nd Ventricles)

• The caudate nucleus and thalamus bulge inward from the lateral walls
• The corpus callosum forms the roof
• The septum pellucidum is a thin membrane separating the two lateral ventricles in the midline
• The fornix dangles from the bottom of the septum pellucidum, paralleling the C-shaped curve
• The hippocampal formation lies on the floor and medial wall of the temporal horn

2. Third Ventricle

• Lateral walls: Thalami and hypothalamus
• Superior: Fornix
• Inferior: Hypothalamus
• Anterior: Anterior commissure, fornix, lamina terminalis, hypothalamus
• Posterior: Posterior commissure, pineal region, hypothalamus

• Supraoptic recess
• Infundibular recess
• Suprapineal recess
• Pineal recess

3. Fourth Ventricle

• Floor (rhomboid fossa): Formed by the dorsal surface of the pons (anteriorly) and medulla (posteriorly)
• Roof: Formed by the cerebellum

• Foramen of Magendie (median aperture) - single midline opening
• Foramina of Luschka (lateral apertures) - paired openings at the lateral recesses

Connecting Passages

CSF Pathway Summary

Choroid plexus (mainly in lateral ventricles) → Lateral ventricles → Foramina of Monro → Third ventricle → Cerebral aqueduct → Fourth ventricle → Foramina of Magendie/Luschka → Subarachnoid space → Arachnoid granulations → Dural venous sinuses → Bloodstream

• Total volume in an adult: ~150 mL
• Rate of production: ~20 mL/hour (~500 mL/day)
• Produced primarily by the choroid plexus in all four ventricles

Lining

• Best for visualizing the frontal horns, body, and occipital horns of the lateral ventricles side by side
• Shows the septum pellucidum dividing the two lateral ventricles in the midline
• The third ventricle appears as a narrow midline slit between the thalami
• The caudate nucleus and thalamus are seen as impressions on the lateral walls
• Used in routine CT head scans to assess ventricular size and midline shift

• Best for appreciating the vertical relationship of all four ventricles stacked together
• Lateral ventricles appear as bilateral paired cavities with the corpus callosum arching over them
• Third ventricle is seen sandwiched between the thalami
• Temporal horns are visible sweeping inferolaterally
• Choroid plexus is visible hanging into the body of the lateral ventricles
• Key plane for detecting transependymal edema in hydrocephalus

• Best for visualizing the complete CSF pathway as a continuous circuit
• The C-shape of the lateral ventricle is fully displayed
• All the recesses of the third ventricle (supraoptic, infundibular, suprapineal, pineal) are visible
• The cerebral aqueduct of Sylvius is seen as a thin channel through the midbrain
• The fourth ventricle and its exit via the foramen of Magendie are clearly shown
• Ideal for detecting aqueductal stenosis (a common cause of obstructive hydrocephalus)

Typhoid Fever (Enteric Fever) - Complete Clinical Overview

Definition

Etiology and Pathogen

• Causative organism: Salmonella typhi (Gram-negative rod, Enterobacteriaceae)
• Antigens: O antigen (somatic), H antigen (flagellar), and Vi antigen (virulence capsular polysaccharide - important for immune evasion and used in vaccines)
• Reservoir: Humans only - cases and carriers (no animal reservoir)
• Survives intracellularly in mononuclear phagocytes; killed by drying, pasteurization, and common disinfectants
• Pathogenesis differs from NTS: S. Typhi does NOT effectively colonize the intestine but instead penetrates the gut mucosa and becomes a systemic pathogen. Mononuclear cell infiltration (not polymorphonuclear) into small bowel mucosa is characteristic

Epidemiology

• Global burden: 9.2-21 million typhoid cases + ~5 million paratyphoid cases annually; 110,000-280,000 deaths/year
• Most burden in South Asia (India, Pakistan, Bangladesh, Nepal) and parts of Africa - incidence exceeds 1,000/100,000 children in some urban areas
• Linked to fecal-oral transmission via contaminated water and food
• Risk factors: contaminated drinking water/ice, street food, raw vegetables grown in sewage-fertilized fields, lack of hand washing, prior H. pylori infection (gastric acidity reduction)

• Temporary carriers: convalescent (excrete for 6-8 weeks), incubatory
• Chronic carriers: defined as excretion >1 year after clinical illness; organisms persist in the gallbladder and biliary tract; develop in 2-5% of cases; may excrete for decades (the famous "Typhoid Mary" caused >1,300 cases in her lifetime)
• Fecal carriers >> urinary carriers; chronic urinary carriage often associated with urinary tract abnormalities

Pathogenesis

Clinical Course (Incubation: 5-21 days, mean 10-14 days)

• Stepladder rising fever (up to 38.8-40.5°C / 101.8-104.9°F)
• Headache, malaise, anorexia, dry cough, constipation (present in ~30% - not always diarrhea)
• Relative bradycardia (pulse-temperature dissociation) - classic sign

• Sustained high fever
• Rose spots - pale pink/red macular rash on the trunk (seen in ~20-30%, mainly fair-skinned patients)
• Splenomegaly and hepatomegaly develop
• Abdominal distention; diarrhea or constipation
• Leukopenia with relative lymphocytosis, elevated liver enzymes

• Possible defervescence spontaneously or complications

Key point: Fever is present at presentation in >75% of cases, but abdominal pain in only 30-40% - so a high index of suspicion is needed in febrile returning travelers.

Complications

Diagnosis

Treatment

First-line antibiotics (uncomplicated typhoid)

Drugs now generally unreliable (resistance)

• Chloramphenicol, Ampicillin, Trimethoprim-sulfamethoxazole - first-line drugs until MDR emergence; now unreliable globally

Severe typhoid / typhoid with meningitis or shock

• Ceftriaxone IV + Dexamethasone (0.3 mg/kg IV loading dose, then 0.1 mg/kg q6h × 8 doses) - shown to reduce mortality in severe disease with altered consciousness or shock

Supportive care

• IV fluids for rehydration
• Blood transfusion if significant GI hemorrhage
• Surgical consultation for intestinal perforation

Carrier treatment

• Ciprofloxacin 750 mg BD × 4 weeks for chronic carriers (combined with cholecystectomy if gallstones present)

Drug Resistance - Current Threat

XDR S. Typhi (H58 clone, Pakistan) is now spreading internationally via air travel. Azithromycin resistance is also emerging in some areas.

Vaccines

• Protection is not complete - revaccination required and food/water precautions must be maintained
• Not effective against paratyphoid
• WHO recommends TCV for routine immunization programs in high-burden countries

Prevention and Control

• Safe water supply and sewage treatment (most impactful)
• Food hygiene and hand washing
• Identification and treatment of chronic carriers
• Vaccination for travelers and endemic populations
• Notification to public health authorities (typhoid is a notifiable disease)